Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Clinical and laboratory characteristics of individuals stratified by 25(OH)D levelsCharacteristicTotal(N = 299)25 (OH)D < 20 ng/ml (N = 180)25 (OH)D ≥ 20 ng/ml (N = 119)p-valueGeneral Age, years (range)80 (35 to 99)81 (35 to 99)72 (36 to 92) < 0.0001 Female gender, n (%)165 (55.2)94 (52.2)71 (59.7)NS BMI (kg/m2)26.6 (13.4 to 41.2)27.2 (13.4 to 41.2)26.0 (14.9 to 38.7)0.0098Smoking status, n (%) Never159 (53.2)97(53.9)62 (52.1)NS Previous116 (38.8)71 (39.4)45 (37.8)NS Current24 (8)12 (6.7)12 (10.1)NSBiochemical parameters 1,25(OH)2D (pg/ml)41.3 (12.4 to 136.0)36.7 (12.4 to 87.5)47 (15.9 to 136.0) < 0.0001 25(OH)D (ng/ml)17.2 (3.5 to 96.0)13 (3.5 to 19.8)27.9 (20.6 to 96.0) < 0.0001 PTH (pmol/L)5.0 (1.2 to 29.5)5.5 (1.2 to 29.5)4.2 (1.3 to 11.4) < 0.0001 VDBP (mg/L)680.4 (351 to 2597)666.3 (351 to 2597)708.1 (382 to 1267)0.36 Creatinine (mg/dL)0.78 (0.14 to 2.77)0.62 (0.14 to 2.11)0.94 (0.29 to 2.77)0.48 BPA (ng/dL)110 (27 to 2807)179.5 (27 to 915)51 (27 to 2807) < 0.0001 Total calcium (mg/dL)9.2 (7.9 to 10.6)9.1 (7.9 to 10.6)9.2 (8.3 to 10.3)0.0095 Magnesium (mg/dl)2.1 (1.2 to 2.8)2.1 (1.6 to 2.4)2.1 (1.5 to 2.8)0.32 Total cholesterol (mg/dL)212 (105 to 542)211.5 (105 to 378)212 (125 to 542)0.53 LDL-cholesterol (mg/dL)131 (34 to 455)130 (34 to 257)132 (61 to 455)0.31 HDL-cholesterol (mg/dL)56 (24 to 115)56 (29 to 109)57.5 (24 to 115)0.07 Triglycerides (mg/dL)98 (29 to 761)104 (32 to 761)94 (29 to 263)0.026 Plasma glucose (mg/dL)92 (57 to 218)94 (70 to 171)90 (57 to 218)0.058Comorbid diseases, n (%) Dyslipidemia144 (48.2)87 (48.3)57 (47.9)NS Hypertension142 (47.5)93 (51.7)49 (41.2)0.08 Fall/fracture/hospitalisation88 (29.4)56 (31.1)31 (26.1)NS Obesity56 (18.7)44 (24.4)12 (10.1)0.002 Osteoporosis48 (16.1)19 (10.6)29 (24.4)0.003 Cardiovascular disease42 (14.0)28 (15.6)14 (11.8)0.4 Type-2 diabetes mellitus39 (13.0)29 (16.1)10 (8.4)0.06 Asthma and/or bronchitis18 (6.0)14 (7.8)4 (3.4)0.14Treatment, n (%) Antihypertensive156 (52.2)104 (57.8)52 (43.7)0.025 Antithrombotic104 (34.8)70 (38.9)34 (28.6)0.08 Psychotropic82 (27.4)52 (28.9)30 (25.2)NS Lipid lowering73 (24.4)48 (26.7)25 (21.0)0.27 Cardiac42 (14.0)28 (15.6)14 (11.8) < 0.0001 Anti-diabetic33 (11.0)23 (12.8)10 (8.4)0.26 Vitamin D supplementation28 (9.4)3 (1.7)25 (21.0) < 0.0001 Anti-fracture15 (5.0)5 (2.8)10 (8.4)0.05Statistically significant p-values (<0.05) are indicated in boldData are presented as number and % or mean and SD.

Source: Clinical and biochemical characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This was a cross-sectional study in a subgroup of elderly people from the InCHIANTI Biobank in Italy.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of vitamin D and bisphenol A levels with cardiovascular risk in an elderly Italian population: results from the InCHIANTI study

Cross-sectional study · GeroScience · 2024

Original publication title

Association of vitamin D and bisphenol A levels with cardiovascular risk in an elderly Italian population: results from the InCHIANTI study

Maria Luisa Brandi; Francesca Marini; Simone Parri; Stefania Bandinelli; Teresa Iantomasi; Francesca Giusti; Eleonora Talluri; Giovanna Sini; Fabrizio Nannipieri; Santina Battaglia; Giovanni Tripepi; Colin Gerard Egan; Luigi Ferrucci

© The Author(s) 2024

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Few studies have evaluated the association between circulating levels of 25-hydroxyvitamin D (25(OH)D), 1,25-dihydroxyvitamin D (1,25(OH)2D), and the endocrine disruptor bisphenol A (BPA), with risk of cardiovascular (CV) disease in elderly individuals. This was a cross-sectional study in a subgroup of elderly people from the InCHIANTI Biobank in Italy. We examined the association between circulating serum vitamin D metabolites, 1,25(OH)2D, 25(OH)D, and the endocrine disrupting agent BPA, with an arbitrary CV risk score and the European Society of Cardiology-based 10-year CV risk (SCORE2/SCORE2-OP) using univariate and multiple regression.

In 299 individuals, blood samples were tested for serum values of 25(OH)D, 1,25(OH)2D and urinary BPA levels. One hundred eighty individuals (60.2%) were deficient (< 20 ng/ml) in 25(OH)D. Levels of 25(OH)D and 1,25(OH)2D were negatively correlated with CV risk score (p < 0.0001 for both) as well as SCORE2/SCORE2-OP (p < 0.0001 for both) while BPA levels were positively correlated with both CV risk scores (p < 0.0001 for both). In a logistic regression model, male gender (odds ratio; OR: 2.1, 95% CI:1.1 to 3.8, p = 0.022), obesity (OR:2.8, 95% CI:1.2 to 6.5, p = 0.016) and BPA levels ≥ 110 ng/dl (OR:20.9, 95% CI:9.4 to 46.8, p < 0.0001) were associated with deficient levels of 25(OH)D. 1,25(OH)2D levels < 41 ng/dl and 25(OH)D levels < 20 ng/ml were associated with CV risk score ≥ 3 (OR: 4.16, 95% CI: 2.32 to 7.4, p < 0.0001 and OR: 1.86, 95% CI: 1.02 to 3.39, p = 0.044) respectively and 1,25(OH)2D levels < 41 ng/dl were associated with SCORE2/SCORE2-OP of ≥ 20% (OR:2.98, 95% CI: 1.7 to 5.2, p = 0.0001).

In this cross-sectional analysis, BPA exposure was associated with significantly reduced levels of vitamin D that in turn were significantly associated with increased CV risk.

Supplementary Information

The online version contains supplementary material available at 10.1007/s11357-024-01193-1.

Authors’ abstract

Few studies have evaluated the association between circulating levels of 25-hydroxyvitamin D (25(OH)D), 1,25-dihydroxyvitamin D (1,25(OH)2D), and the endocrine disruptor bisphenol A (BPA), with risk of cardiovascular (CV) disease in elderly individuals. This was a cross-sectional study in a subgroup of elderly people from the InCHIANTI Biobank in Italy. We examined the association between circulating serum vitamin D metabolites, 1,25(OH)2D, 25(OH)D, and the endocrine disrupting agent BPA, with an arbitrary CV risk score and the European Society of Cardiology-based 10-year CV risk (SCORE2/SCORE2-OP) using univariate and multiple regression.

In 299 individuals, blood samples were tested for serum values of 25(OH)D, 1,25(OH)2D and urinary BPA levels. One hundred eighty individuals (60.2%) were deficient (< 20 ng/ml) in 25(OH)D. Levels of 25(OH)D and 1,25(OH)2D were negatively correlated with CV risk score (p < 0.0001 for both) as well as SCORE2/SCORE2-OP (p < 0.0001 for both) while BPA levels were positively correlated with both CV risk scores (p < 0.0001 for both). In a logistic regression model, male gender (odds ratio; OR: 2.1, 95% CI:1.1 to 3.8, p = 0.022), obesity (OR:2.8, 95% CI:1.2 to 6.5, p = 0.016) and BPA levels ≥ 110 ng/dl (OR:20.9, 95% CI:9.4 to 46.8, p < 0.0001) were associated with deficient levels of 25(OH)D. 1,25(OH)2D levels < 41 ng/dl and 25(OH)D levels < 20 ng/ml were associated with CV risk score ≥ 3 (OR: 4.16, 95% CI: 2.32 to 7.4, p < 0.0001 and OR: 1.86, 95% CI: 1.02 to 3.39, p = 0.044) respectively and 1,25(OH)2D levels < 41 ng/dl were associated with SCORE2/SCORE2-OP of ≥ 20% (OR:2.98, 95% CI: 1.7 to 5.2, p = 0.0001).

In this cross-sectional analysis, BPA exposure was associated with significantly reduced levels of vitamin D that in turn were significantly associated with increased CV risk.

Supplementary Information

The online version contains supplementary material available at 10.1007/s11357-024-01193-1.

Publication and source details

Original title: Association of vitamin D and bisphenol A levels with cardiovascular risk in an elderly Italian population: results from the InCHIANTI study

Maria Luisa Brandi; Francesca Marini; Simone Parri; Stefania Bandinelli; Teresa Iantomasi; Francesca Giusti; Eleonora Talluri; Giovanna Sini; Fabrizio Nannipieri; Santina Battaglia; Giovanni Tripepi; Colin Gerard Egan; Luigi Ferrucci

GeroScience · 2024

© The Author(s) 20242024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100003196Ministero della SaluteICS110.1/RF97.71Brandi Maria Luisa

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:03:40.826321+00:00

DOI: 10.1007/s11357-024-01193-1 · PMC11494005